AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial
logo

ATXS(Quitar la ciudad)

Astria Therapeutics·NASDAQ
--
--(--)
5.42 / 10
Neutral

Capital flows are positive overall (score 7.63/10), with block, small, medium, and extra-large inflows trending upward—except for a slight negative bias in large-cap flows. This indicates institutional accumulation despite the neutral technical backdrop. Analyst coverage is thin (only one active analyst) with a unanimous Neutral rating, and the historical weighted rating is 3.20, reflecting limited conviction. The sentiment score of 5.42 is neutral, aligning with the cautious analyst stance and mixed fund flow signals.

FundamentalSentimiento(5.42)Técnico
Calificación de flujo de fondos
Calificación del analistaCompra fuerte

Opiniones de Wall Street

Compra fuerte

Compra fuerte

0%

Comprar

0%

Sostener

0%

Vender

0%

Venta fuerte

0%

Fecha2025-11-12
InstituciónCantor Fitzgerald
Tiempos previstos3
Tasa histórica de ganancias66.7%